NKY(SZ:300109) Sou Hu Cai Jing·2025-03-27 09:16Group 1 - The core viewpoint of the articles highlights the performance and valuation of Xin Kai Yuan, which closed at 17.92 yuan, up 8.02%, with a rolling PE ratio of 21.75, marking a new low in 196 days, and a total market capitalization of 8.686 billion yuan [1] - The average PE ratio for the chemical products industry is 47.15, with a median of 38.11, placing Xin Kai Yuan at the 67th position in the industry ranking [1][2] - In terms of capital flow, Xin Kai Yuan saw a net inflow of 47.8002 million yuan on March 27, with a total inflow of 18.7937 million yuan over the past five days [1] Group 2 - Xin Kai Yuan's main business includes fine chemicals and precision medicine, with key products such as PVPK30, PVP-I, and various diagnostic services [1] - The latest financial results for the third quarter of 2024 show that the company achieved an operating income of 1.111 billion yuan, a year-on-year decrease of 7.92%, and a net profit of 311 million yuan, down 23.13%, with a gross profit margin of 52.10% [1]